Buy and hold these ASX 200 shares: experts

If you’re a fan of buying and holding ASX 200 shares then you might want to consider the two listed below.

Both have been named as buys and tipped to deliver solid long term growth. Here’s what you need to know about these ASX 200 shares:

Breville Group Ltd (ASX: BRG)

This leading appliance manufacturer could be an ASX 200 share to buy for the long term.

Breville has been growing at a solid rate for over a decade. This has been driven by the popularity of its brands, its international expansion, successful acquisitions, and its investment in research and development.

The good news is that all these drivers remain in place and Breville appears well-positioned to replicate its success over the next decade. Particularly given its exposure to the growing premium coffee in-home consumption trend.

It is partly for this reason that Morgans currently has an rating and $25.00 price target on its shares.

Cochlear Limited (ASX: COH)

Another ASX 200 share that could be a top buy and hold option is Cochlear.

Like Breville, it has been growing at a consistently solid rate for at least a decade. This has been driven by its world class hearings solutions portfolio and growing demand.

And with demand only expected to increase as the global population ages, Cochlear appears well-placed for more of the same over the next decade. Particularly given the industry’s high barriers of entry and its sizeable investment in research and development. The latter looks set to help the company maintain its leadership position for the foreseeable future.

Goldman Sachs is very positive on Cochlear. It currently has a buy rating and $247.00 price target on its shares.

The post Buy and hold these ASX 200 shares: experts appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Why experts say these ASX 200 blue chip shares are buys
• 10 ASX stocks to buy before they report this earnings season: Goldman
• A new bull market is coming: 3 ASX shares I’d load up on before it gets here
• Goldman reveals the ASX shares that could surprise to the upside (and downside) this reporting season
• Here are the top 10 ASX 200 shares today

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear. The Motley Fool Australia has recommended Cochlear. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/s0uFgZA